abstract |
The present patent provides a pharmaceutical composition comprising one cholesterol absorption inhibitor and one HMG-CoA reductase inhibitor, one or more antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose. The composition should not contain ascorbic acid in order to maintain the desired stability. |